Keyphrases
Shock
100%
Inflammatory Response
100%
LPS-induced Inflammation
100%
Pseudomonas Aeruginosa Infection
100%
Endotoxin
100%
Heparin Cofactor II
100%
Helix
66%
Sepsis
66%
Improved Survival
33%
Antimicrobial
33%
Bacterial Growth
33%
Major Contributor
33%
Novel Therapeutics
33%
Long Peptides
33%
Gram-positive Bacilli
33%
Sepsis Shock
33%
Inflammatory Cytokine Response
33%
Septic Shock
33%
NF-B
33%
Escherichia Coli
33%
Systemic Inflammatory Response
33%
High Mortality Rate
33%
Staphylococcus Aureus
33%
Antibiotics
33%
Candida Albicans (C. albicans)
33%
Medical Problems
33%
Novel Treatments
33%
Mouse Model
33%
Invasive Infection
33%
Activator protein-1 (AP-1)
33%
Treatment Options
33%
Inflammatory Cytokines
33%
Pseudomonas Aeruginosa (P. aeruginosa)
33%
Antimicrobial Activity
33%
Bacillus Subtilis (B. subtilis)
33%
Fungi
33%
Gram-negative Bacteria
33%
Amino Acids
33%
Infection Model
33%
Therapeutic Candidates
33%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Endotoxin
100%
Pseudomonas Infection
100%
Sepsis
75%
Gram Positive Bacterium
25%
Antibiotics
25%
Candida albicans
25%
Septic Shock
25%
Antimicrobial Agent
25%
Diseases
25%
Staphylococcus aureus
25%
Infection
25%
Mortality Rate
25%
Antiinfective Agent
25%
Gram Negative Infection
25%
Pseudomonas aeruginosa
25%
Mouse Model
25%
Gram Negative Bacterium
25%
Amino Acid
25%
Escherichia coli
25%
Cytokine
25%
Immunology and Microbiology
Peptides
100%
Pseudomonas aeruginosa
100%
Inflammation Response
100%
Cytokine Response
25%
Escherichia coli
25%
Mortality Rate
25%
Gram-Positive Bacteria
25%
Amino Acid
25%
Proinflammatory Cytokine
25%
Candida albicans
25%
Pseudomonas
25%
Staphylococcus aureus
25%
Bacterial Growth
25%
Bacillus subtilis
25%
Mouse Model
25%
Gram-Negative Bacteria
25%
Antimicrobial Agent
25%